Form 8-K - Current report:
SEC Accession No. 0001193125-25-226992
Filing Date
2025-10-01
Accepted
2025-10-01 17:14:46
Documents
12
Period of Report
2025-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sclx-20250930.htm   iXBRL 8-K 63468
2 EX-10.1 sclx-ex10_1.htm EX-10.1 236015
3 EX-10.2 sclx-ex10_2.htm EX-10.2 273992
  Complete submission text file 0001193125-25-226992.txt   824717

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sclx-20250930.xsd EX-101.SCH 63753
14 EXTRACTED XBRL INSTANCE DOCUMENT sclx-20250930_htm.xml XML 6480
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 251365528
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)